Breast Lesion Localization Methods Market Report 2025

The breast lesion localization methods market size has grown rapidly in recent years. It will grow from $1.5 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 11%. The growth during the historic period can be attributed to increasing disposable incomes, heightened awareness of early detection, rising demand for minimally invasive surgeries, greater adoption of image-guided procedures, and expanded availability of advanced diagnostic tools.

The breast lesion localization methods market size is expected to see rapid growth in the next few years. It will grow to $2.5 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to an expanding aging population, rising healthcare expenditures, broader availability of reimbursement policies, increasing demand for personalized treatments, and greater adoption of minimally invasive procedures. Key trends during the forecast period include advancements in wireless localization technologies, innovations in magnetic and radar-based localization, integration of artificial intelligence into imaging systems, development of advanced image-guided surgical techniques, and incorporation of emerging technologies.

The rising incidence of breast cancer is expected to drive the growth of the breast lesion localization methods market in the coming years. Breast cancer occurs when cells in the breast grow uncontrollably, forming tumors that can often be detected via X-ray or physical examination. This increase in cases is largely driven by longer life expectancy, as aging is a major risk factor for breast tumor development. Breast lesion localization methods support breast cancer treatment by precisely identifying and marking abnormal tissue, enabling surgeons to remove tumors accurately while preserving healthy breast tissue. For example, according to the American Association for Cancer Research, a US-based nonprofit organization, around 2.3 million people were diagnosed with breast cancer, and approximately 670,000 died from the disease globally in 2022. If trends continue, diagnoses could reach 3.2 million cases with 1.1 million deaths annually by 2050. Consequently, the rising incidence of breast cancer is fueling the growth of the breast lesion localization methods market.

Leading companies in this market are developing advanced solutions, such as radar-guided wire-free breast lesion localization systems, to improve surgical precision, patient comfort, and outcomes in breast-conserving procedures. Radar reflector localization systems use a small radar reflector implanted at the tumor site prior to surgery to guide surgeons. For instance, in December 2022, Merit Medical Systems, Inc., a US-based manufacturer of disposable medical devices, launched Scout Bx, a wireless radar-guided system that assists surgeons in identifying biopsied tumors for removal. Scout Bx improves precision and patient comfort compared to traditional wire-based localization, enabling more effective incision planning and minimizing healthy tissue removal. Its wire-free design also reduces patient anxiety, eliminates scheduling constraints between radiology and surgery, and allows placement days or weeks before the procedure. The system is especially useful for dense breast tissue, providing real-time guidance and improved workflow efficiency.

In July 2024, Hologic, Inc., a US-based medical technology company, acquired Endomagnetics Ltd. for an undisclosed amount. This acquisition strengthens Hologic’s breast cancer surgery portfolio, expands its presence in the breast health market, and provides more comprehensive, radiation-free options for tumor localization and lymphatic mapping. Endomagnetics Ltd., a UK-based medical device company, specializes in magnetic markers and guidance systems used in breast lesion localization surgery.

Major players in the breast lesion localization methods market are Becton, Dickinson and Company, Hologic Inc., Halma Plc, Cook Medical LLC, Merit Medical Systems Inc., Argon Medical Devices Inc., Eckert & Ziegler AG, Theragenics Corporation, SOMATEX Medical Technologies GmbH, BPB Medica S.r.l., Devicor Medical Products Inc., Cianna Medical Inc., Mermaid Medical A/S, Ranfac Corporation, Sirius Medical B.V., MOLLI Surgical Inc., IsoAid LLC, STERYLAB S.r.l., MDL S.r.l., Biomedical Srl.

North America was the largest region in the breast lesion localization methods market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in breast lesion localization methods market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the breast lesion localization methods market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Breast lesion localization methods are medical techniques used to accurately identify the position of abnormal tissue within the breast prior to a clinical procedure. These methods assist healthcare professionals in targeting the specific area of concern while minimizing damage to surrounding healthy tissue.

The primary types of breast lesion localization methods include wire localization, radioactive seed localization, magnetic seed localization, ultrasound-guided localization, and needle localization. Wire localization is a conventional approach used to mark the position of a breast lesion before surgery. These methods have multiple uses, including tumor identification and sentinel lymph node localization, and employ various technologies such as radioactive, magnetic, and radiofrequency systems. Applications span breast biopsy, breast-conserving surgery, neoadjuvant therapy, and others, serving end users like hospitals, ambulatory surgical centers, specialty clinics, and academic and research institutions.

The breast lesion localization methods market research report is one of a series of new reports that provides breast lesion localization methods market statistics, including breast lesion localization methods industry global market size, regional shares, competitors with a breast lesion localization methods market share, breast lesion localization methods market segments, market trends and opportunities, and any further data you may need to thrive in the breast lesion localization methods industry. This breast lesion localization methods market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The breast lesion localization methods market consists of revenues earned by entities by providing services such as imaging guided biopsy services, stereotactic core biopsy, and dynamic angiothermography. The market value includes the value of related goods sold by the service provider or included within the service offering. The breast lesion localization methods market also includes sales of localization wires, magnetic markers, radar reflectors, and related imaging guidance systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.